B. Sands

Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease

W. Sandborn, B. Feagan, J. Johanns, 2023, Journal of Patient-Reported Outcomes.

Occurrence of Colon Ischemia in Relation to Irritable Bowel Syndrome

B. Sands, A. Walker, S. Cook, 2004, American Journal of Gastroenterology.

Validation of the Functional Assessment of Chronic Illness Therapy‐Fatigue (FACIT‐F) in patients with inflammatory bowel disease

J. Korzenik, B. Sands, A. Tinsley, 2011, Alimentary pharmacology & therapeutics.

Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials

V. Jairath, T. Gibble, Taku Kobayashi, 2024, Expert review of gastroenterology & hepatology.

Clinical Trial Design in Ulcerative Colitis: Interpreting Evolving Endpoints Based on Post Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1

S. Uddin, W. Sandborn, B. Sands, 2023, Crohn's & colitis 360.

Efficacy and Safety of Ustekinumab as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI

S. Targan, G. Van Assche, L. Peyrin-Biroulet, 2019, Zeitschrift für Gastroenterologie.